Research Paper Volume 15, Issue 6 pp 1878—1889

A multi-omics approach based on 1H-NMR metabonomics combined with target protein analysis to reveal the mechanism of RIAISs on cervical carcinoma patients


Figure 4. The integral analysis of quantitation proteomics, metabonomics and COPD associated proteins. (A) 1H NMR-based metabolomic analysis of faces, serum, and urine sample. Quantitation of metabolites with the condition of Fold-change ≥1.2 or ≤0.83 and p-value ≤0.05. (B) KEGG pathway enrichment analysis of differential metabolites.